iMedix Medical Content Engine 3.13.37

Amitriptyline: Uses, dosage, side effects, warnings & patient reviews

Amitriptyline

Amitriptyline

Amitriptyline

Amitriptyline hydrochloride
Amitriptyline is a tricyclic antidepressant (TCA). It is indicated for the treatment of major depressive disorder. Its pharmacological properties also lead to its use in the management of certain chronic pain conditions and migraine prevention under medical supervision.
  • ActiveIngredient: Amitriptyline hydrochloride
  • DosageForm: Oral tablets
  • Dosage: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg.
  • Indications: Treatment of depression (Major Depressive Disorder).
  • Manufacturer: Sandoz, Mylan (Viatris), Teva Pharmaceuticals, and other generic manufacturers. (Brand name Elavil is discontinued in the U.S.).
  • Storage: Store at room temperature 20°C–25°C (68°F–77°F) in a tight, light-resistant container.
  • Drug Status: Prescription Only

What is Amitriptyline (Elavil)?

Amitriptyline, formerly marketed under the brand name Elavil, is a prescription medication belonging to the tricyclic antidepressant (TCA) class. It works primarily by increasing the levels of the neurotransmitters serotonin and norepinephrine in the brain by inhibiting their reuptake into nerve cells.

The medication’s effects are not limited to mood regulation. Due to its influence on neurotransmitter systems, it is also used in the management of chronic neuropathic pain and for the prevention of migraine headaches. These latter uses are often considered off-label, meaning they are based on clinical practice and research rather than the original FDA approval.

Amitriptyline is known for its significant sedative and anticholinergic properties, which contribute to its side effect profile and influence its clinical use.

How to Take Amitriptyline

Amitriptyline must be taken exactly as prescribed by a healthcare provider. Deviating from the prescribed regimen can increase risks and reduce effectiveness.

Dosage and Administration

Dosage is highly individualized. For depression in adults, treatment often begins with a low dose, such as amitriptyline 25 mg or amitriptyline 10 mg at bedtime. The dose may be gradually increased by the prescribing physician at weekly intervals based on therapeutic response and tolerability.

The full therapeutic effect for depression may take 4 to 6 weeks to become apparent. The medication should not be stopped abruptly, as this can cause withdrawal symptoms. Dosage must be tapered slowly under medical direction.

Timing and Duration

Due to its sedating effects, amitriptyline is typically taken as a single daily dose at bedtime. This can help minimize daytime drowsiness and utilize the sedation to aid sleep. The duration of treatment is determined by the treating physician based on the underlying condition.

Side Effects of Amitriptyline

Amitriptyline is associated with a range of side effects, primarily due to its anticholinergic and sedative properties. Their severity and occurrence vary among individuals.

Common and Serious Side Effects of Amitriptyline
FrequencySide EffectsNotes
Very Common
  • Drowsiness, sedation
  • Dry mouth
  • Blurred vision
  • Constipation
  • Dizziness, orthostatic hypotension (lightheadedness upon standing)
  • Weight gain
These anticholinergic and sedative effects are often most pronounced when starting treatment and may diminish over time. Persistent dry mouth can increase dental caries risk; see information on oral health.
Serious (Require Medical Attention)
  • Significant cardiac rhythm changes (palpitations, fast/irregular heartbeat)
  • Severe dizziness/fainting
  • Difficulty urinating or urinary retention (men with BPH are at higher risk; see BPH information)
  • Worsening depression, new or increased suicidal thoughts or behaviors
  • Seizures
  • Signs of liver problems (yellowing skin/eyes, dark urine)
  • Serotonin syndrome (agitation, hallucinations, fever, fast heart rate)
Discontinue use and seek immediate medical evaluation if any of these occur. The risk of suicidal thoughts is highest in young adults and requires close monitoring.

What is Amitriptyline Used For?

Amitriptyline is prescribed for several conditions, both FDA-approved and off-label, based on its mechanism of action.

FDA-Approved Use

Major Depressive Disorder: Amitriptyline is indicated for the treatment of symptoms of major depression.

Common Off-Label Uses

Under physician supervision, amitriptyline is frequently prescribed for:

  • Chronic Neuropathic Pain: Such as diabetic neuropathy or postherpetic neuralgia. Doses are often lower than those for depression.
  • Migraine Prophylaxis: For the prevention of migraine headaches.
  • Fibromyalgia: As part of a comprehensive management plan.
  • Insomnia: Its sedative effect may be utilized in low doses for sleep disturbance, particularly when associated with depression or chronic pain. For more on sleep aids, see this category.

Interactions Alcohol:

Unsafe
Concurrent use of alcohol and amitriptyline is contraindicated. Alcohol potentiates the central nervous system (CNS) depressant effects of amitriptyline, significantly increasing risks of severe drowsiness, dizziness, impaired judgment, and respiratory depression.

Interactions Other Medications:

Consult your doctor
Amitriptyline interacts with many drugs. Combining it with monoamine oxidase inhibitors (MAOIs) is life-threatening. Concomitant use with other CNS depressants (e.g., opioids, benzodiazepines) increases sedation risk. It may also interact with drugs affecting cardiac rhythm, such as certain antibiotics. For details on specific cardiac interactions, see information on medications like erythromycin.

Special Groups Pregnancy:

Consult your doctor
Amitriptyline is in Pregnancy Category C. Data on use during human pregnancy is limited. The potential risks and benefits must be carefully evaluated by a healthcare provider. Use during the third trimester may lead to neonatal withdrawal symptoms.

Special Groups Breastfeeding:

Consult your doctor
Amitriptyline is excreted in breast milk in low concentrations. The decision to breastfeed while taking this medication requires a risk-benefit assessment by a physician, considering potential effects on the infant.

Special Groups Elderly:

Use with caution
Elderly patients are more sensitive to anticholinergic effects (confusion, dizziness, dry mouth), sedation, and orthostatic hypotension, increasing fall risk. Amitriptyline may also worsen cognitive impairment in patients with or at risk for dementia. Lower starting doses are mandatory.

Special Groups Children:

Consult your doctor
Amitriptyline is not typically a first-line treatment for depression in patients under 18 due to the black box warning regarding increased risk of suicidal thoughts and behaviors. Its use in this population requires rigorous clinical justification and close monitoring.

Effects on Activities Driving:

Unsafe
Amitriptyline commonly causes drowsiness, dizziness, and blurred vision, which severely impair the ability to drive or operate vehicles safely. Patients must not drive until they know how the medication affects them. For more on this risk, see this safety guide.

Effects on Activities Operating Machinery:

Unsafe
For the same reasons as driving, operating heavy machinery or engaging in hazardous activities is unsafe while taking amitriptyline, especially during initial treatment or dose adjustments.

Important Safety Concerns and Considerations

Suicidality and Antidepressant Use

Amitriptyline carries a FDA Boxed Warning regarding the increased risk of suicidal thinking and behavior in children, adolescents, and young adults (up to age 24) during initial treatment (first few months) or during dose changes. All patients starting therapy require close monitoring for clinical worsening, suicidality, or unusual changes in behavior.

Cardiovascular Effects

Amitriptyline can cause conduction abnormalities, including QT interval prolongation, and may lead to arrhythmias, tachycardia, and orthostatic hypotension. It is contraindicated in the acute recovery phase after a myocardial infarction. An electrocardiogram (ECG) may be recommended before initiation in some patients, especially those with pre-existing heart conditions.

Seizure Threshold

Amitriptyline can lower the seizure threshold. Caution is advised in patients with a history of seizures or conditions that predispose to them.

Anticholinergic Effects

Strong anticholinergic activity can lead to dry mouth, blurred vision, urinary retention, constipation, and cognitive impairment. These effects are particularly problematic for the elderly and those with dementia, benign prostatic hyperplasia (BPH), or narrow-angle glaucoma.

Narrow Therapeutic Index and Overdose

Tricyclic antidepressants have a narrow therapeutic index, meaning the difference between a therapeutic dose and a toxic dose is small. Overdose is extremely dangerous and can be fatal, causing severe cardiac arrhythmias, seizures, and coma. It requires immediate emergency intervention. Medication must be stored securely. For critical information, see a guide on accidental overdose.

Critical Warnings for Amitriptyline Use

Black Box Warning: Suicidality

Antidepressants increased the risk of suicidal thoughts and behavior in pediatric and young adult patients in short-term studies. Monitor all patients closely for clinical worsening and emergence of suicidal thoughts, especially at treatment initiation and during dosage adjustments.

Monoamine Oxidase Inhibitor (MAOI) Interaction

Amitriptyline is contraindicated in patients taking MAOIs or within 14 days of stopping an MAOI due to the risk of serotonin syndrome, a potentially life-threatening condition characterized by high fever, seizures, and autonomic instability.

Cardiac Contraindications and Precautions

Use is contraindicated during the acute recovery phase after myocardial infarction. Amitriptyline should be used with extreme caution in patients with a history of cardiovascular disease, conduction abnormalities, or a recent heart attack due to risks of arrhythmia and hypotension.

Glaucoma and Urinary Retention

Due to its anticholinergic effects, amitriptyline is generally contraindicated in patients with narrow-angle glaucoma. It should be used with caution in patients with urinary retention or symptomatic prostate hypertrophy, as it can worsen these conditions. Patients using medications for BPH or glaucoma, such as bimatoprost, should inform their doctor.

Amitriptyline Dosage Information

Dosage must be individualized by a physician. The following are general guidelines for adults. Therapy usually starts at a low dose to minimize side effects, with gradual upward titration.

Amitriptyline Dosage Guidelines
IndicationTypical Adult Starting DoseTypical Maintenance Dose RangeNotes
Major Depression25 mg to 50 mg at bedtime50 mg to 150 mg dailyDose may be increased gradually. Maximum dose seldom exceeds 300 mg/day in hospitalized patients.
Neuropathic Pain / Migraine Prevention (Off-label)10 mg to 25 mg at bedtime25 mg to 75 mg dailyOften effective at lower doses than those used for depression. Higher doses may be used if tolerated and effective.
Geriatric or Debilitated Patients10 mg at bedtime25 mg to 50 mg dailyLower doses are used due to increased sensitivity to side effects and slower metabolism.

Important Administration Notes

  • Single Daily Dosing: The full daily dose is often given once at bedtime to minimize daytime sedation and utilize the sedative effect for sleep.
  • Gradual Discontinuation: To avoid withdrawal symptoms (nausea, headache, malaise), the dose should be tapered slowly over several weeks under medical supervision, not stopped abruptly.
  • Therapeutic Lag: Full antidepressant effect may not be seen for 4 to 6 weeks, although some effects (e.g., sedation) are immediate.

Drug Interactions with Amitriptyline

Amitriptyline has numerous clinically significant drug interactions. A complete review of all medications, including over-the-counter drugs and supplements, with the prescribing physician is essential.

Significant Drug Interactions with Amitriptyline
Interacting Substance Class/ExamplePotential Effect of InteractionRecommendation
Monoamine Oxidase Inhibitors (MAOIs)
(e.g., phenelzine, selegiline, linezolid)
Risk of severe, potentially fatal serotonin syndrome or hypertensive crisis.Absolute contraindication. A minimum 14-day washout period is required between therapies.
Other Serotonergic Drugs
(SSRIs, SNRIs, tramadol, triptans, St. John’s Wort)
Increased risk of serotonin syndrome.Combination should be avoided or used with extreme caution and close monitoring.
CNS Depressants
(Alcohol, opioids, benzodiazepines, sedative antihistamines)
Additive CNS depression, leading to profound sedation, respiratory depression, and impaired psychomotor function.Avoid concurrent use. If necessary, use with extreme caution and dose adjustment.
Anticholinergic Drugs
(e.g., some antihistamines, antiparkinson drugs, antipsychotics)
Additive anticholinergic effects (dry mouth, urinary retention, constipation, confusion).Increased monitoring for side effects is required.
Drugs that Prolong QT Interval
(Certain antiarrhythmics, antibiotics, antipsychotics)
Additive effect on cardiac repolarization, increasing the risk of serious arrhythmias (torsades de pointes).Combination generally not recommended. ECG monitoring may be necessary.
Enzyme Inhibitors/Inducers
Inhibitors: Cimetidine, SSRIs
Inducers: Barbiturates, carbamazepine
Inhibitors increase amitriptyline blood levels (increased toxicity risk). Inducers decrease levels (reduced efficacy).Dose adjustments of amitriptyline are likely required.

FAQs

No. While its FDA-approved indication is for major depressive disorder, it is very commonly prescribed off-label for chronic neuropathic pain conditions (e.g., diabetic neuropathy), migraine headache prevention, and fibromyalgia. For these conditions, it is used for its analgesic and neuromodulatory properties, often at lower doses.
Amitriptyline has strong sedative effects. Taking the entire daily dose at bedtime helps mitigate problematic daytime drowsiness and can simultaneously address insomnia that often accompanies depression or chronic pain.
Yes, weight gain is a commonly reported side effect. The mechanism is multifactorial and may involve increased appetite, carbohydrate craving, and metabolic changes. Patients concerned about this effect should discuss it with their doctor. For related information, see the weight loss medication category.
While the sedative effect is immediate, the analgesic or preventive effect for pain conditions may take several weeks to become fully apparent. A therapeutic trial of 6 to 8 weeks at an adequate dose is typically required to assess efficacy.
Amitriptyline is not considered addictive in the same way as substances like opioids or benzodiazepines. It does not produce euphoria or cravings. However, abruptly stopping the medication after long-term use can cause withdrawal symptoms (dizziness, nausea, headache, irritability), which is why a gradual taper under medical supervision is necessary.

Additional Information

Storage and Handling

Store at room temperature, away from light and moisture. Keep in the original container, tightly closed, and out of reach of children and pets. Due to the high risk of fatal overdose, secure storage is paramount.

Overdose and Toxicity

Tricyclic antidepressant overdose is a medical emergency. Symptoms can include severe drowsiness, agitation, confusion, hallucinations, high fever, irregular heart rate, seizures, and coma. If an overdose is suspected, call emergency services immediately.

Monitoring Requirements

Treatment with amitriptyline may require periodic monitoring, which can include assessment of mood and suicidality (especially in young patients), heart rate and blood pressure checks, and possibly blood level monitoring or ECGs in certain clinical situations (e.g., high-dose therapy, elderly patients, pre-existing cardiac conditions).

References and Medical Sources

  1. U.S. Food and Drug Administration (FDA). Amitriptyline Hydrochloride Tablets Prescribing Information. [Revised 2019]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/085968s112lbl.pdf
  2. MedlinePlus. Amitriptyline. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a682388.html
  3. National Institute for Health and Care Excellence (NICE). Neuropathic pain in adults: pharmacological management. Clinical guideline [CG173]. https://www.nice.org.uk/guidance/cg173
  4. Drugs.com. Amitriptyline Professional Monograph. https://www.drugs.com/monograph/amitriptyline.html

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.

You must login to add a comment.

Popular Questions

Top Members

Join the discussion

Comments are published after moderation. User opinions do not constitute medical advice.

We sincerely appreciate you taking the time to share your feedback. Every user's perspective is valuable to us.

Ask to get answers.